While Little Pink **** may not be perfect, the campaign to get the drug approved dealt with the possibility of gender disparity issues in the FDAís approval record. There are around six approved drugs that treat menís erectile dysfunction and before Addyi, there were none for women. Some feminists and activists claim that this is due to an unconscious bias in the FDA and in the scientific community that develops these drugs. Not only are there fewer treatment options for women, but women actually suffer from ***ual dysfunction more than men. For decades menís ***ual dysfunction has been prioritized over womenís. The FDA continually denies these claims, but recognizes that female ***ual dysfunction is in its top 20 priority areas of unmet medical needs. Little Pink **** is now availed for free trial from its official website http://www.pinkgarciniafacts.com/lit...-****-reviews/